News
Feb 20, 2026
AbstractBackground and Objectives: Hereditary transthyretin amyloidosis (ATTRv) is a rare disease caused by pathogenic variants in the transthyretin (TTR) gene.…
Feb 20, 2026
Insulin-derived amyloidosis is a rare form of localised amyloidosis resulting from the aggregation of exogenous insulin into subcutaneous amyloid fibrils at…
Feb 20, 2026
AbstractAntibodies directed at the amyloid-β peptide offer the prospect of disease-modifying therapy for early-stage Alzheimer disease but also carry the risk of…
Feb 20, 2026
We are raising funds in loving memory of our mum, who sadly passed away from cardiac amyloidosis on 10/12/2025.Amyloidosis is a rare and often misunderstood…
Feb 20, 2026
Amyloidosis is a rare, chronic condition in which abnormal proteins bunch together to form amyloid deposits. These deposits can build in certain body organs such as…
Feb 20, 2026
Carlisle, PA… Now in its third decade of doing good for those impacted by Amyloidosis, the Chip Miller Amyloidosis Foundation (CMAF) works year-round to raise…
Feb 20, 2026
NORD and Yale Genetics are hosting a Rare Disease Day celebration at the Yale Peabody Museum! Join us for a night of community building & connection. Attendees…
Feb 20, 2026
Join NORD’s Pennsylvania Rare Action Network for a virtual Rare Disease Day celebration on Friday, February 20 from 12pm to 1:10pm ET
Feb 19, 2026
Net cash used in operating and investing activities was $23.3 million and $163.7 million for the fourth quarter and full year of 2025, respectively; quarter-end…
Feb 19, 2026
Isatuximab monotherapy resulted in promising hematologic response rates with a good safety profile among patients with relapsed/refractory (R/R) light chain (AL)…